Case Series: The Challenge of Using Immune Checkpoint Inhibitors in Anti-Transcriptional Intermediary Factor 1 γ$$ \gamma $$ Antibody-Positive Dermatomyositis.发表在期刊《International Journal of Rheumatic Diseases》上,发表时间:2025-01-01,作者:Liang Chen, Sabrina Fallavollita, Lama Sakr, Hangjun Wang, Marc Pusztaszeri, Khashayar Esfahani, Michael N Pollak, Marie Hudson, Valérie Leclair" />
Case Series: The Challenge of Using Immune Checkpoint Inhibitors in Anti-Transcriptional Intermediary Factor 1 γ$$ \gamma $$ Antibody-Positive Dermatomyositis.
Liang Chen, Sabrina Fallavollita, Lama Sakr, Hangjun Wang, Marc Pusztaszeri, Khashayar Esfahani, Michael N Pollak, Marie Hudson, Valérie Leclair
{"title":"<ArticleTitle xmlns:ns0=\"http://www.w3.org/1998/Math/MathML\">Case Series: The Challenge of Using Immune Checkpoint Inhibitors in Anti-Transcriptional Intermediary Factor 1 <ns0:math> <ns0:semantics><ns0:mrow><ns0:mi>γ</ns0:mi></ns0:mrow> <ns0:annotation>$$ \\gamma $$</ns0:annotation></ns0:semantics> </ns0:math> Antibody-Positive Dermatomyositis.","authors":"Liang Chen, Sabrina Fallavollita, Lama Sakr, Hangjun Wang, Marc Pusztaszeri, Khashayar Esfahani, Michael N Pollak, Marie Hudson, Valérie Leclair","doi":"10.1111/1756-185X.70087","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":14330,"journal":{"name":"International Journal of Rheumatic Diseases","volume":"28 1","pages":"e70087"},"PeriodicalIF":2.4000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Rheumatic Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/1756-185X.70087","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
期刊介绍:
The International Journal of Rheumatic Diseases (formerly APLAR Journal of Rheumatology) is the official journal of the Asia Pacific League of Associations for Rheumatology. The Journal accepts original articles on clinical or experimental research pertinent to the rheumatic diseases, work on connective tissue diseases and other immune and allergic disorders. The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor.